Biotech Startups
10,056 companies tagged Biotech, with their investors and founders.
Pike develops a multi-day, continuous-delivery patch formulation of dronabinol to address non-motor symptoms in Parkinson's Disease and agitation in Alzheimer's and dementia patients.
0 investors
0 investors
Pimera is a privately held biopharmaceutical company developing small-molecule cancer therapeutics, including RNA polymerase I inhibitors that activate nucleolar stress to treat hematologic and other cancers. It focuses on oncology drug discovery and development.
0 investors
Pinnacle Transplant Technologies processes and distributes allograft implants — including demineralized bone matrix products, soft tissue grafts, structural grafts, and amniotic membranes — for orthopedic and wound healing applications. It also offers contract manufacturing and private-labeled implants for medical device customers.
0 investors
PinPoint Testing provides analytical laboratory services and consulting for the detection of drugs, environmental hazards, food toxins, and industrial contaminants, serving pharmaceutical, clinical, forensic, and government laboratories. The company operates a CLIA and ISO 17025-accredited forensic testing lab and offers ToxBox product solutions and reference laboratory services.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
PTX is a biotech company developing therapeutic solutions to mitigate adverse side effects associated with cancer chemotherapy and other medical treatments. The company focuses on improving patient quality of life during medical therapies through drug development.
0 investors
PleoPharma is a pharmaceutical company developing a treatment aimed at an unmet medical condition. It works with industry partners, healthcare providers, researchers, and investors.
0 investors
Plexiform Bio is developing non-invasive treatments for retinal vascular diseases, which are currently treated primarily through injections into the eye. The company aims to offer alternatives to frequent, uncomfortable eye injections for patients with retinal conditions that cause blurred vision.
0 investors
0 investors
Pluristyx develops induced pluripotent stem cell (iPSC) technologies, including non-modified and genetically engineered cell lines, proprietary gene edits, and reprogramming platforms, along with related services. It provides these products and end-to-end development support to companies building cell and stem cell therapies.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors